Third Arc Bio
Victoria Demby (nee Thiel) currently serves as the Senior Vice President of Global Regulatory Affairs and Quality at Third Arc Bio since May 2025. Demby also holds the position of Adjunct Assistant Professor at The George Washington University School of Medicine and Health Sciences. Previously, Demby was Senior Vice President of Global Regulatory Affairs for Oncology at Adlai Nortye USA Inc., and held key roles at GSK, Merck, and Bristol-Myers Squibb focusing on regulatory strategy and leadership in oncology and pharmaceutical safety. Demby has also contributed to academia as a lecturer at the University of Wisconsin-Madison and as an invited lecturer and board member at the University of Maryland. Demby's educational background includes a PhD in Pharmacology and Toxicology from The University of Kansas and a BS in Biochemistry from the University of Vermont.
This person is not in any teams
This person is not in any offices
Third Arc Bio
Third Arc Bio is a biotech company developing multifunctional antibodies that generate immune synapses that precisely activate or inhibit T cells. The company’s drug development engine delivers superior biologics optimized to create best-in-class T cell engagement by leveraging two technologies that power a pipeline of high value therapeutics – a solid tumor synergy platform and an I&I platform that offers a novel approach to precision immune regulation at a tissue-specific level to achieve superior efficacy and safety. To learn more, visit www.thirdarcbio.com.